Is LUV Stock a Buy, Sell or Hold?
Southwest Airlines (NYSE:LUV) is one of America’s major air transportation…
Sell
6
SINT Quote, Financials, Valuation and Earnings
Last price:
$2.51
Seasonality move
:
30.09%
Day range:
$2.43 - $2.64
52-week range:
$2.01 - $45.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.62x
P/B ratio:
1.67x
Volume:
41.6K
Avg. volume:
321.2K
1-year change:
-68.34%
Market cap:
$6.5M
Revenue:
$1.2M
EPS (TTM):
-$33.83
Analysts' Opinion
-
Consensus RatingSINTX Technologies has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $300.00, SINTX Technologies has an estimated upside of 2602.7% from its current price of $2.59.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $300.00 representing 100% downside risk from its current price of $2.59.
Fair Value
-
According to the consensus of 1 analyst, SINTX Technologies has 2602.7% upside to fair value with a price target of $300.00 per share.
SINT vs. S&P 500
-
Over the past 5 trading days, SINTX Technologies has underperformed the S&P 500 by -13.01% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
SINTX Technologies does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
SINTX Technologies revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter SINTX Technologies reported revenues of $192K.
Earnings Growth
-
SINTX Technologies has grown year-over-year earnings for 0 quarters straight. In the most recent quarter SINTX Technologies reported earnings per share of -$1.26.
Enterprise value:
2.9M
EV / Invested capital:
--
Price / LTM sales:
1.62x
EV / EBIT:
--
EV / Revenue:
2.37x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.32x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$916K
Return On Assets:
-79.96%
Net Income Margin (TTM):
-884.75%
Return On Equity:
-148.9%
Return On Invested Capital:
-146.19%
Operating Margin:
-826.56%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $601K | $1.2M | $1.2M | $583K | $192K | |
| Gross Profit | $336K | $715K | $916K | $138K | $38K | |
| Operating Income | -$11.3M | -$13.1M | -$8.6M | -$2.7M | -$1.6M | |
| EBITDA | -$11.1M | -$6.6M | -$9.6M | -$1.9M | -$1.5M | |
| Diluted EPS | -$10,673.62 | -$773.14 | -$33.83 | -$108.63 | -$1.26 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $27.6M | $15M | $7.2M | $5.5M | $4.8M | |
| Total Assets | $30.4M | $21.8M | $15.8M | $15.4M | $9.4M | |
| Current Liabilities | $2.9M | $2.7M | $8.1M | $2.9M | $2M | |
| Total Liabilities | $4.6M | $4.6M | $10.1M | $6.6M | $5.5M | |
| Total Equity | $25.8M | $17.2M | $5.7M | $8.8M | $3.9M | |
| Total Debt | $396K | $509K | $528K | $46K | $32K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$10.3M | -$14.1M | -$8.6M | -$3.1M | -$1.1M | |
| Cash From Investing | -$1.1M | -$501K | -$194K | -$62K | $10K | |
| Cash From Financing | $3.3M | $11.7M | $9.1M | $311K | -$102K | |
| Free Cash Flow | -$11.7M | -$14.6M | -$9.3M | -$3.2M | -$1.3M | |
SINT
Sector
Market Cap
$6.5M
$35.9M
Price % of 52-Week High
5.68%
43.21%
Dividend Yield
0%
0%
Shareholder Yield
0.17%
-0.91%
1-Year Price Total Return
-68.34%
-43.29%
Beta (5-Year)
1.124
0.746
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$2.79
200-day SMA
Sell
Level
$3.75
Bollinger Bands (100)
Sell
Level
2.71 - 4.11
Chaikin Money Flow
Sell
Level
-60.4M
20-day SMA
Sell
Level
$3.01
Relative Strength Index (RSI14)
Sell
Level
37.27
ADX Line
Buy
Level
20.5
Williams %R
Buy
Level
-83.4783
50-day SMA
Sell
Level
$3.32
MACD (12, 26)
Sell
Level
-0.23
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Neutral
Level
213.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-44.7587)
Sell
CA Score
(Annual)
Level (-4.3758)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (7.8651)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
Stock Forecast FAQ
In the current month, SINT has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The SINT average analyst price target in the past 3 months is $300.00.
-
Where Will SINTX Technologies Stock Be In 1 Year?
According to analysts, the consensus estimate is that SINTX Technologies share price will rise to $300.00 per share over the next 12 months.
-
What Do Analysts Say About SINTX Technologies?
Analysts are divided on their view about SINTX Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that SINTX Technologies is a Sell and believe this share price will drop from its current level to $300.00.
-
What Is SINTX Technologies's Price Target?
The price target for SINTX Technologies over the next 1-year time period is forecast to be $300.00 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is SINT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for SINTX Technologies is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of SINT?
You can purchase shares of SINTX Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase SINTX Technologies shares.
-
What Is The SINTX Technologies Share Price Today?
SINTX Technologies was last trading at $2.51 per share. This represents the most recent stock quote for SINTX Technologies. Yesterday, SINTX Technologies closed at $2.59 per share.
-
How To Buy SINTX Technologies Stock Online?
In order to purchase SINTX Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Should I Buy Alcoa Stock?
Alcoa (AA) finds itself in an interesting position in early…
Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
43
MNPR alert for Apr 3
Monopar Therapeutics [MNPR] is down 7.22% over the past day.
Buy
75
BKTI alert for Apr 3
BK Technologies [BKTI] is down 9.26% over the past day.
Sell
34
SWTX alert for Apr 3
SpringWorks Therapeutics [SWTX] is down 6.26% over the past day.
